-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUPHORIA THERAPEUTICS INC - LPLV MILESTONE IN AFFIRM-1 PHASE 3 TRIAL OF OF BNC-210 IN SAD ACHIEVED, SEES TOPLINE READOUT IN Q4

Reuters·09/29/2025 20:54:40

Please log in to view news